Industry: Chemical & Material
Published Date: 2025-09-10
Pages: 80 Pages
Report ld: 4798862
Request Sample
Customized Report
Actinium-225 Market Size(US$)

CAGR 2025-2031
21.4%
Market Size,2031
USD 4.5
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Actinium-225 market size was US$ 1.1 million in 2024 and is forecast to a readjusted size of US$ 4.5 million by 2031 with a CAGR of 21.4% during the forecast period 2025-2031.
By 2025, the evolving U.S. tariff policy is poised to inject considerable uncertainty into the global economic landscape. This report delves into the latest U.S. tariff measures and the corresponding policy responses across the globe, evaluating their impacts on Actinium-225 market competitiveness, regional economic performance, and supply chain configurations.
Actinium-225 (225Ac, Ac-225) is an isotope of actinium. It undergoes alpha decay to francium-221 with a half-life of 10 days, and is an intermediate decay product in the neptunium series (the decay chain starting at 237Np). Except for minuscule quantities arising from this decay chain in nature, 225Ac is entirely synthetic.
The decay properties of actinium-225 are favorable for usage in targeted alpha therapy (TAT); clinical trials have demonstrated the applicability of radiopharmaceuticals containing 225Ac to treat various types of cancer. However, the scarcity of this isotope resulting from its necessary synthesis in cyclotrons limits its potential applications.
Actinium-225 can be attached to molecules to target cancer in the human body. In global clinical trials for advanced metastatic prostate cancer, radioactive isotopes have been shown to be effective in eliminating cancer. Therefore, actinium-225 has broad application prospects in the field of anti-cancer.
Scientific research: Actinium-225 occurs naturally, but obtaining large amounts of purified material requires an accelerator or nuclear reactor, as well as the facilities and expertise to chemically separate actinium-255 from the hundreds of isotopes produced during production. Therefore, research on actinium-225 not only helps promote the development of nuclear science, but also helps promote research in related fields.
Market demand: As people's requirements for health and quality of life continue to increase, the demand for medical technology and equipment is also increasing. As a potential medical isotope, the market demand for actinium-225 is also increasing.
Medical applications: Actinium-225 has a high linear energy transfer density (LET) and can emit 4 alpha particles and 2 beta particles in the decay chain, ultimately generating stable bismuth-209 (209Bi). Therefore, it is considered as a promising nuclear medicine targeted nuclide therapy research.
The global Actinium-225 market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Actinium-225 market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Thorium-229 Decay in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Cancer Therapy in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Actinium-225 value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Actinium-225 Product Scope
1.2 Actinium-225 by Type
1.2.1 Global Actinium-225 Sales by Type (2020 & 2024 & 2031)
1.2.2 Accelerator
1.2.3 Thorium-229 Decay
1.3 Actinium-225 by Application
1.3.1 Global Actinium-225 Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Scientific Research
1.3.3 Cancer Therapy
1.4 Global Actinium-225 Market Estimates and Forecasts (2020-2031)
1.4.1 Global Actinium-225 Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Actinium-225 Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Actinium-225 Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Actinium-225 Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Actinium-225 Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Actinium-225 Sales Market Share by Region (2020-2025)
2.2.2 Global Actinium-225 Revenue Market Share by Region (2020-2025)
2.3 Global Actinium-225 Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Actinium-225 Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Actinium-225 Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Actinium-225 Market Size and Prospective (2020-2031)
2.4.2 Europe Actinium-225 Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Actinium-225 Historic Market Review by Type (2020-2025)
3.1.1 Global Actinium-225 Sales by Type (2020-2025)
3.1.2 Global Actinium-225 Revenue by Type (2020-2025)
3.1.3 Global Actinium-225 Price by Type (2020-2025)
3.2 Global Actinium-225 Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Actinium-225 Sales Forecast by Type (2026-2031)
3.2.2 Global Actinium-225 Revenue Forecast by Type (2026-2031)
3.2.3 Global Actinium-225 Price Forecast by Type (2026-2031)
3.3 Different Types Actinium-225 Representative Players
4 Global Market Size by Application
4.1 Global Actinium-225 Historic Market Review by Application (2020-2025)
4.1.1 Global Actinium-225 Sales by Application (2020-2025)
4.1.2 Global Actinium-225 Revenue by Application (2020-2025)
4.1.3 Global Actinium-225 Price by Application (2020-2025)
4.2 Global Actinium-225 Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Actinium-225 Sales Forecast by Application (2026-2031)
4.2.2 Global Actinium-225 Revenue Forecast by Application (2026-2031)
4.2.3 Global Actinium-225 Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Actinium-225 Application
5 Competition Landscape by Players
5.1 Global Actinium-225 Sales by Players (2020-2025)
5.2 Global Top Actinium-225 Players by Revenue (2020-2025)
5.3 Global Actinium-225 Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Actinium-225 as of 2024)
5.4 Global Actinium-225 Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Actinium-225, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Actinium-225, Product Type & Application
5.7 Global Key Manufacturers of Actinium-225, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Actinium-225 Sales by Company
6.1.1.1 North America Actinium-225 Sales by Company (2020-2025)
6.1.1.2 North America Actinium-225 Revenue by Company (2020-2025)
6.1.2 North America Actinium-225 Sales Breakdown by Type (2020-2025)
6.1.3 North America Actinium-225 Sales Breakdown by Application (2020-2025)
6.1.4 North America Actinium-225 Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Actinium-225 Sales by Company
6.2.1.1 Europe Actinium-225 Sales by Company (2020-2025)
6.2.1.2 Europe Actinium-225 Revenue by Company (2020-2025)
6.2.2 Europe Actinium-225 Sales Breakdown by Type (2020-2025)
6.2.3 Europe Actinium-225 Sales Breakdown by Application (2020-2025)
6.2.4 Europe Actinium-225 Major Customer
6.2.5 Europe Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 ORNL
7.1.1 ORNL Company Information
7.1.2 ORNL Business Overview
7.1.3 ORNL Actinium-225 Sales, Revenue and Gross Margin (2020-2025)
7.1.4 ORNL Actinium-225 Products Offered
7.1.5 ORNL Recent Development
7.2 TerraPower
7.2.1 TerraPower Company Information
7.2.2 TerraPower Business Overview
7.2.3 TerraPower Actinium-225 Sales, Revenue and Gross Margin (2020-2025)
7.2.4 TerraPower Actinium-225 Products Offered
7.2.5 TerraPower Recent Development
7.3 Tri-Lab
7.3.1 Tri-Lab Company Information
7.3.2 Tri-Lab Business Overview
7.3.3 Tri-Lab Actinium-225 Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Tri-Lab Actinium-225 Products Offered
7.3.5 Tri-Lab Recent Development
7.4 SSC RF-IPPE
7.4.1 SSC RF-IPPE Company Information
7.4.2 SSC RF-IPPE Business Overview
7.4.3 SSC RF-IPPE Actinium-225 Sales, Revenue and Gross Margin (2020-2025)
7.4.4 SSC RF-IPPE Actinium-225 Products Offered
7.4.5 SSC RF-IPPE Recent Development
7.5 JRC Karlsruhe
7.5.1 JRC Karlsruhe Company Information
7.5.2 JRC Karlsruhe Business Overview
7.5.3 JRC Karlsruhe Actinium-225 Sales, Revenue and Gross Margin (2020-2025)
7.5.4 JRC Karlsruhe Actinium-225 Products Offered
7.5.5 JRC Karlsruhe Recent Development
7.6 TRIUMF
7.6.1 TRIUMF Company Information
7.6.2 TRIUMF Business Overview
7.6.3 TRIUMF Actinium-225 Sales, Revenue and Gross Margin (2020-2025)
7.6.4 TRIUMF Actinium-225 Products Offered
7.6.5 TRIUMF Recent Development
7.7 Eckert&Ziegler
7.7.1 Eckert&Ziegler Company Information
7.7.2 Eckert&Ziegler Business Overview
7.7.3 Eckert&Ziegler Actinium-225 Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Eckert&Ziegler Actinium-225 Products Offered
7.7.5 Eckert&Ziegler Recent Development
8 Actinium-225 Manufacturing Cost Analysis
8.1 Actinium-225 Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Actinium-225
8.4 Actinium-225 Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Actinium-225 Distributors List
9.3 Actinium-225 Customers
10 Actinium-225 Market Dynamics
10.1 Actinium-225 Industry Trends
10.2 Actinium-225 Market Drivers
10.3 Actinium-225 Market Challenges
10.4 Actinium-225 Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Actinium-225 market size was US$ 1.4 million in 2025 and is forecast to reach a readjusted size of US$ 5.35 million by 2032 with a CAGR of 21.4% during the forecast period 2026-2032.
Published Date: 2026-01-05
Pages: 76
USD 4250.00
(Single User License)
The global Actinium-225 market was valued at US$ 1.4 million in 2025 and is anticipated to reach US$ 5.35 million by 2032, at a CAGR of 21.4% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 128
USD 2900.00
(Single User License)
The global market for Actinium-225 was estimated to be worth US$ 1.4 million in 2025 and is projected to reach US$ 5.35 million, growing at a CAGR of 21.4% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 108
USD 3950.00
(Single User License)
The global Actinium-225 market is projected to grow from US$ 1.1 million in 2024 to US$ 4.5 million by 2031, at a CAGR of 21.4% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-07-31
Pages: 141
USD 4900.00
(Single User License)
The global market for Actinium-225 was valued at US$ 1.1 million in the year 2024 and is projected to reach a revised size of US$ 4.5 million by 2031, growing at a CAGR of 21.4% during the forecast period.
Published Date: 2025-07-24
Pages: 92
USD 2900.00
(Single User License)
The global market for Actinium-225 was valued at be worth US$ 1.08 million in 2024 and is forecast to a readjusted size of US$ 4.48 million by 2031 with a CAGR of 21.41% during the forecast period 2025-2031.
Published Date: 2025-02-17
Pages: 106
USD 3950.00
(Single User License)
The global market for Actinium-225 was estimated to be worth US$ 0.7 million in 2024 and is forecast to a readjusted size of US$ 1.8 million by 2031 with a CAGR of 15.2% during the forecast period 2025-2031.
Published Date: 2025-01-19
Pages: 97
USD 3950.00
(Single User License)
Actinium-225 (225Ac, Ac-225) is an isotope of actinium. It undergoes alpha decay to francium-221 with a half-life of 10 days, and is an intermediate decay product in the neptunium series (the decay chain starting at 237Np). Except for minuscule quantities arising from this decay chain in nature, 225Ac is entirely synthetic. The decay properties of actinium-225 are favorable for usage in targeted alpha therapy (TAT); clinical trials have demonstrated the applicability of radiopharmaceuticals containing 225Ac to treat various types of cancer. However, the scarcity of this isotope resulting from its necessary synthesis in cyclotrons limits its potential applications.
Published Date: 2024-07-22
Pages: 113
USD 4350.00
(Single User License)
Actinium-225 (225Ac, Ac-225) is an isotope of actinium. It undergoes alpha decay to francium-221 with a half-life of 10 days, and is an intermediate decay product in the neptunium series (the decay chain starting at 237Np). Except for minuscule quantities arising from this decay chain in nature, 225Ac is entirely synthetic. The decay properties of actinium-225 are favorable for usage in targeted alpha therapy (TAT); clinical trials have demonstrated the applicability of radiopharmaceuticals containing 225Ac to treat various types of cancer. However, the scarcity of this isotope resulting from its necessary synthesis in cyclotrons limits its potential applications.
Published Date: 2024-07-22
Pages: 105
USD 3950.00
(Single User License)
Actinium-225 (225Ac, Ac-225) is an isotope of actinium. It undergoes alpha decay to francium-221 with a half-life of 10 days, and is an intermediate decay product in the neptunium series (the decay chain starting at 237Np). Except for minuscule quantities arising from this decay chain in nature, 225Ac is entirely synthetic. The decay properties of actinium-225 are favorable for usage in targeted alpha therapy (TAT); clinical trials have demonstrated the applicability of radiopharmaceuticals containing 225Ac to treat various types of cancer. However, the scarcity of this isotope resulting from its necessary synthesis in cyclotrons limits its potential applications.
Published Date: 2024-07-22
Pages: 143
USD 4900.00
(Single User License)
The global Actinium-225 market size was US$ 1.4 million in 2025 and is forecast to reach a readjusted size of US$ 5.35 million by 2032 with a CAGR of 21.4% during the forecast period 2026-2032.
Published: 2026-01-05
Pages: 76
The global Actinium-225 market was valued at US$ 1.4 million in 2025 and is anticipated to reach US$ 5.35 million by 2032, at a CAGR of 21.4% from 2026 to 2032.
Published: 2026-01-05
Pages: 128
The global market for Actinium-225 was estimated to be worth US$ 1.4 million in 2025 and is projected to reach US$ 5.35 million, growing at a CAGR of 21.4% from 2026 to 2032.
Published: 2026-01-05
Pages: 108
The global Actinium-225 market is projected to grow from US$ 1.1 million in 2024 to US$ 4.5 million by 2031, at a CAGR of 21.4% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-07-31
Pages: 141
The global market for Actinium-225 was valued at US$ 1.1 million in the year 2024 and is projected to reach a revised size of US$ 4.5 million by 2031, growing at a CAGR of 21.4% during the forecast period.
Published: 2025-07-24
Pages: 92
The global market for Actinium-225 was valued at be worth US$ 1.08 million in 2024 and is forecast to a readjusted size of US$ 4.48 million by 2031 with a CAGR of 21.41% during the forecast period 2025-2031.
Published: 2025-02-17
Pages: 106
The global market for Actinium-225 was estimated to be worth US$ 0.7 million in 2024 and is forecast to a readjusted size of US$ 1.8 million by 2031 with a CAGR of 15.2% during the forecast period 2025-2031.
Published: 2025-01-19
Pages: 97
Actinium-225 (225Ac, Ac-225) is an isotope of actinium. It undergoes alpha decay to francium-221 with a half-life of 10 days, and is an intermediate decay product in the neptunium series (the decay chain starting at 237Np). Except for minuscule quantities arising from this decay chain in nature, 225Ac is entirely synthetic. The decay properties of actinium-225 are favorable for usage in targeted alpha therapy (TAT); clinical trials have demonstrated the applicability of radiopharmaceuticals containing 225Ac to treat various types of cancer. However, the scarcity of this isotope resulting from its necessary synthesis in cyclotrons limits its potential applications.
Published: 2024-07-22
Pages: 113
Actinium-225 (225Ac, Ac-225) is an isotope of actinium. It undergoes alpha decay to francium-221 with a half-life of 10 days, and is an intermediate decay product in the neptunium series (the decay chain starting at 237Np). Except for minuscule quantities arising from this decay chain in nature, 225Ac is entirely synthetic. The decay properties of actinium-225 are favorable for usage in targeted alpha therapy (TAT); clinical trials have demonstrated the applicability of radiopharmaceuticals containing 225Ac to treat various types of cancer. However, the scarcity of this isotope resulting from its necessary synthesis in cyclotrons limits its potential applications.
Published: 2024-07-22
Pages: 105
Actinium-225 (225Ac, Ac-225) is an isotope of actinium. It undergoes alpha decay to francium-221 with a half-life of 10 days, and is an intermediate decay product in the neptunium series (the decay chain starting at 237Np). Except for minuscule quantities arising from this decay chain in nature, 225Ac is entirely synthetic. The decay properties of actinium-225 are favorable for usage in targeted alpha therapy (TAT); clinical trials have demonstrated the applicability of radiopharmaceuticals containing 225Ac to treat various types of cancer. However, the scarcity of this isotope resulting from its necessary synthesis in cyclotrons limits its potential applications.
Published: 2024-07-22
Pages: 143
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now